Literature DB >> 14512714

Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia.

Anders Wallin1, Magnus Sjögren, Kaj Blennow, Pia Davidsson.   

Abstract

The main objective was to investigate the acetylcholinesterase E (AChE) activity in the cerebrospinal fluid (CSF) of patients with three common dementia disorders. We also wanted to investigate the influence of apolipoprotein E (ApoE) epsilon4 allele possession and CSF-tau level on the CSF-AChE activity in these patients. The study included 17 consecutive patients with subcortical vascular dementia (SVD), 39 with Alzheimer's disease (AD), 14 with frontotemporal dementia (FTD) and 12 controls. CSF was obtained by lumbar puncture and CSF-AChE activity was measured by an enzyme antigen immunoassay. CSF-AchE activity was significantly decreased compared to controls only in the SVD group (p = 0.010). The CSF-tau level was increased in the AD group compared to the control (p < 0.01) and FTD groups (p < 0.05). No influence of ApoE epsilon4 allele possession on CSF-AChE activity was found. It is suggested that abnormal CSF-AChE activity in patients with SVD reflects a disturbance in the cholinergic system. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512714     DOI: 10.1159/000072803

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  13 in total

Review 1.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

Review 2.  Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Authors:  Anders Lönneborg
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 3.  CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.

Authors:  Hanna Rosenmann
Journal:  J Mol Neurosci       Date:  2011-11-05       Impact factor: 3.444

4.  Correlations between cholinesterase activity and cognitive scores in post-ischemic rats and patients with vascular dementia.

Authors:  Yan Xiao; Zhi-Zhong Guan; Chang-Xue Wu; Yi Li; Shi-Xiang Kuang; Jin-Jing Pei
Journal:  Cell Mol Neurobiol       Date:  2011-11-17       Impact factor: 5.046

Review 5.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

6.  Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia.

Authors:  José María García-Alberca; Silvia Mendoza; Esther Gris
Journal:  Clin Drug Investig       Date:  2022-03-28       Impact factor: 3.580

7.  Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

Authors:  Per Johansson; Erik G Almqvist; Jan-Ove Johansson; Niklas Mattsson; Ulf Andreasson; Oskar Hansson; Anders Wallin; Kaj Blennow; Henrik Zetterberg; Johan Svensson
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

8.  Cholinergic depletion and basal forebrain volume in primary progressive aphasia.

Authors:  Jolien Schaeverbeke; Charlotte Evenepoel; Rose Bruffaerts; Koen Van Laere; Guy Bormans; Eva Dries; Thomas Tousseyn; Natalie Nelissen; Ronald Peeters; Mathieu Vandenbulcke; Patrick Dupont; Rik Vandenberghe
Journal:  Neuroimage Clin       Date:  2016-12-02       Impact factor: 4.881

Review 9.  Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

10.  White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia.

Authors:  Qing Liu; Zude Zhu; Stefan J Teipel; Jianwei Yang; Yi Xing; Yi Tang; Jianping Jia
Journal:  Front Aging Neurosci       Date:  2017-02-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.